1. Home
  2. LMFA vs GOVX Comparison

LMFA vs GOVX Comparison

Compare LMFA & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LM Funding America Inc.

LMFA

LM Funding America Inc.

HOLD

Current Price

$0.38

Market Cap

5.6M

Sector

Finance

ML Signal

HOLD

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$1.56

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMFA
GOVX
Founded
2008
2001
Country
United States
United States
Employees
19
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
2.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
LMFA
GOVX
Price
$0.38
$1.56
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$5.00
$200.00
AVG Volume (30 Days)
275.5K
128.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
28.08
N/A
EPS
N/A
N/A
Revenue
$10,999,648.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$0.12
52 Week High
$5.14
$4.40

Technical Indicators

Market Signals
Indicator
LMFA
GOVX
Relative Strength Index (RSI) 48.66 40.02
Support Level $0.30 $0.55
Resistance Level $0.43 $4.40
Average True Range (ATR) 0.04 0.24
MACD 0.01 -0.07
Stochastic Oscillator 58.18 20.70

Price Performance

Historical Comparison
LMFA
GOVX

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: